TARGETED TWO-PHOTON PHOTODYNAMIC THERAPY TRIADS
The objectives are to further the pre-clinical development of unique two-photon activated Photodynamic Therapy (PTD) triads that incorporate a photosensitizer, a tumor receptor targeting group, and an imaging functionality, providing a noninvasive treatment of recurrent and refractory Head and Neck (HandN) tumors deep below the skin surface, in an outpatient setting.
Small Business Information at Submission:
Principal Investigator:Charles Spangler
SENSOPATH TECHNOLOGIES, INC.
920 Technology Blvd STE B BOZEMAN, MT 59718-
Number of Employees: